{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T16:55:59Z","timestamp":1782320159074,"version":"3.54.5"},"reference-count":23,"publisher":"Elsevier BV","issue":"24","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer, Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.vaccine.2019.03.032","type":"journal-article","created":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T17:01:58Z","timestamp":1553706118000},"page":"3241-3250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Seropersistence and booster response following vaccination with FSME-IMMUN in children, adolescents, and young adults"],"prefix":"10.1016","volume":"37","author":[{"given":"E.","family":"Poellabauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Angermayr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Behre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Harper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HJ.","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Erber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.vaccine.2019.03.032_b0005","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.idc.2008.03.013","article-title":"Tick-borne encephalitis","volume":"22","author":"Kaiser","year":"2008","journal-title":"Infect Dis Clin North Am"},{"issue":"9627","key":"10.1016\/j.vaccine.2019.03.032_b0010","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0140-6736(08)60800-4","article-title":"Tick-borne encephalitis","volume":"371","author":"Lindquist","year":"2008","journal-title":"The Lancet"},{"issue":"7","key":"10.1016\/j.vaccine.2019.03.032_b0015","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.vaccine.2007.11.046","article-title":"After a tick bite in a tick-borne encephalitis virus endemic area: current positions about post-exposure treatment","volume":"26","author":"Broker","year":"2008","journal-title":"Vaccine"},{"issue":"Pt 11","key":"10.1016\/j.vaccine.2019.03.032_b0020","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1093\/brain\/122.11.2067","article-title":"The clinical and epidemiological profile of tick-borne encephalitis in southern Germany 1994\u201398: a prospective study of 656 patients","volume":"122","author":"Kaiser","year":"1999","journal-title":"Brain: J Neurol"},{"issue":"9","key":"10.1016\/j.vaccine.2019.03.032_b0025","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1586\/erv.12.86","article-title":"Vaccines and vaccination against tick-borne encephalitis","volume":"11","author":"Kollaritsch","year":"2012","journal-title":"Expert Rev Vacc"},{"issue":"8","key":"10.1016\/j.vaccine.2019.03.032_b0030","doi-asserted-by":"crossref","first-page":"551","DOI":"10.4161\/hv.5.8.8571","article-title":"Seropersistence of tick-borne encephalitis antibodies, safety and booster response to FSME-IMMUN 0.5 ml in adults aged 18\u201367 years","volume":"5","author":"Loew-Baselli","year":"2009","journal-title":"Human Vacc"},{"issue":"11","key":"10.1016\/j.vaccine.2019.03.032_b0035","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1080\/00365540110027358","article-title":"Pharmacokinetics of human tick-borne encephalitis virus antibody levels after injection with human tick-borne encephalitis immunoglobulin, solvent\/detergent treated, FSME-BULIN S\/D in healthy volunteers","volume":"33","author":"Adner","year":"2001","journal-title":"Scand J Infect Dis"},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2019.03.032_b0040","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S0264-410X(02)00593-5","article-title":"Tolerability of modified tick-borne encephalitis vaccine FSME-IMMUN \u201cNEW\u201d in children: results of post-marketing surveillance","volume":"21","author":"Pavlova","year":"2003","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2019.03.032_b0045","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.vaccine.2004.07.002","article-title":"Immunogenicity and safety of a booster vaccination against tick-borne encephalitis more than 3 years following the last immunisation","volume":"23","author":"Rendi-Wagner","year":"2004","journal-title":"Vaccine"},{"issue":"50","key":"10.1016\/j.vaccine.2019.03.032_b0050","doi-asserted-by":"crossref","first-page":"7027","DOI":"10.1016\/j.vaccine.2009.09.068","article-title":"Booster vaccinations against tick-borne encephalitis: 6 Years follow-up indicates long-term protection","volume":"27","author":"Paulke-Korinek","year":"2009","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2019.03.032_b0055","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.vaccine.2008.11.082","article-title":"Long-term persistence of tick-borne encephalitis antibodies in adults 5 years after booster vaccination with Encepur Adults","volume":"27","author":"Plentz","year":"2009","journal-title":"Vaccine"},{"issue":"27","key":"10.1016\/j.vaccine.2019.03.032_b0060","doi-asserted-by":"crossref","first-page":"5097","DOI":"10.1016\/j.vaccine.2007.01.116","article-title":"Antibody persistence following booster vaccination against tick-borne encephalitis: 3-year post-booster follow-up","volume":"25","author":"Rendi-Wagner","year":"2007","journal-title":"Vaccine"},{"issue":"Suppl 40","key":"10.1016\/j.vaccine.2019.03.032_b0065","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ijmm.2006.01.030","article-title":"Persistence of antibodies after vaccination against tick-borne encephalitis","volume":"296","author":"Rendi-Wagner","year":"2006","journal-title":"Int J Med Microbiol: IJMM."},{"issue":"28","key":"10.1016\/j.vaccine.2019.03.032_b0070","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1016\/j.vaccine.2017.03.059","article-title":"Seropersistence of TBE virus antibodies 10 years after first booster vaccination and response to a second booster vaccination with FSME-IMMUN 0.5\u202fmL in adults","volume":"35","author":"Konior","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.03.032_b0075","article-title":"Second five-year follow-up after a booster vaccination against tick-borne encephalitis following different primary vaccination schedules demonstrates at least 10years antibody persistence","author":"Beran","year":"2018","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2019.03.032_b0080","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3201\/eid1901.120458","article-title":"Vaccination and tick-borne encephalitis, central Europe","volume":"19","author":"Heinz","year":"2013","journal-title":"Emerg Infect Dis"},{"issue":"13","key":"10.1016\/j.vaccine.2019.03.032_b0085","doi-asserted-by":"crossref","first-page":"20756","DOI":"10.2807\/1560-7917.ES2014.19.13.20756","article-title":"Epidemiology of tick-borne encephalitis in Switzerland, 2005 to 2011","volume":"19","author":"Schuler","year":"2014","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.vaccine.2019.03.032_b0090","series-title":"Paper presented at: Northern European Conference on Travel Medicine (NECTM), Stokholm, Sweden","article-title":"Duration of protection by Tick-Borne Encephalitis (TBE) vaccines: opening a debate","author":"Steffen","year":"2018"},{"key":"10.1016\/j.vaccine.2019.03.032_b0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0204844","article-title":"Tick-borne encephalitis: a 43 year summary of epidemiological and clinical data from Latvia (1973 to 2016)","author":"Zavadska","year":"2018","journal-title":"PLoS ONE"},{"issue":"16","key":"10.1016\/j.vaccine.2019.03.032_b0100","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1016\/j.vaccine.2010.02.001","article-title":"Vaccine failures after active immunisation against tick-borne encephalitis","volume":"28","author":"Andersson","year":"2010","journal-title":"Vaccine"},{"issue":"20","key":"10.1016\/j.vaccine.2019.03.032_b0105","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1016\/j.vaccine.2014.01.072","article-title":"Irregular tick-borne encephalitis vaccination schedules: the effect of a single catch-up vaccination with FSME-IMMUN. A prospective non-interventional study","volume":"32","author":"Schosser","year":"2014","journal-title":"Vaccine"},{"issue":"43","key":"10.1016\/j.vaccine.2019.03.032_b0110","doi-asserted-by":"crossref","first-page":"7307","DOI":"10.1016\/j.vaccine.2011.07.089","article-title":"Prevention of tick-borne encephalitis by FSME-IMMUN vaccines: review of a clinical development programme","volume":"29","author":"Loew-Baselli","year":"2011","journal-title":"Vaccine"},{"issue":"50","key":"10.1016\/j.vaccine.2019.03.032_b0115","doi-asserted-by":"crossref","first-page":"7021","DOI":"10.1016\/j.vaccine.2009.09.069","article-title":"Characteristics of antibody responses in tick-borne encephalitis vaccination breakthroughs","volume":"27","author":"Stiasny","year":"2009","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19303548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19303548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:33:19Z","timestamp":1759401199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19303548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":23,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0264410X19303548"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.03.032","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seropersistence and booster response following vaccination with FSME-IMMUN in children, adolescents, and young adults","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.03.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}